Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Tuberculosis and Respiratory Diseases
>
2019
>
82
>
2
Volume:
82
Issue:
2
1. Erratum: Smoking Cessation Strategies Targeting Specific Populations
Page:178—178
2. Trends and Updated Statistics of Lung Cancer in Korea
Page:175—177
3. Expanding Use of the ProVent Score
Page:173—174
4. Association between Medical Costs and the ProVent Model in Patients Requiring Prolonged Mechanical Ventilation
Page:166—172
5. Potential Therapeutic Strategy in Chronic Obstructive Pulmonary Disease Using Pioglitazone-Augmented Wharton's Jelly-Derived Mesenchymal Stem Cells
Page:158—165
6. Pre-immigration Screening for Tuberculosis in South Korea: A Comparison of Smear- and Culture-Based Protocols
Page:151—157
7. Correlation between GenoType MTBDRplus Assay and Phenotypic Susceptibility Test for Prothionamide in Patients with Genotypic Isoniazid Resistance
Page:143—150
8. Bleomycin Inhibits Proliferation via Schlafen-Mediated Cell Cycle Arrest in Mouse Alveolar Epithelial Cells
Page:133—142
9. Identification of Serial DNA Methylation Changes in the Blood Samples of Patients with Lung Cancer
Page:126—132
10. Clinical Characteristics and Prognostic Factors of Lung Cancer in Korea: A Pilot Study of Data from the Korean Nationwide Lung Cancer Registry
Page:118—125
11. Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 2. Idiopathic Pulmonary Fibrosis
Page:102—117
12. Infection Source and Epidemiology of Nontuberculous Mycobacterial Lung Disease
Page:94—101
13. The Development of the Korean Lung Cancer Registry (KALC-R)
Page:91—93